05/07/2024
3:46 PM | Kiniksa Pharmaceuticals (Issuer)
Levy Richard S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:35 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
3:36 PM | Kiniksa Pharmaceuticals (Filer)
| Form DEF 14A | |
04/23/2024
3:41 PM | Kiniksa Pharmaceuticals (Filer)
| Form ARS | |
04/23/2024
3:43 PM | Kiniksa Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2024
3:46 PM | Kiniksa Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2024
6:34 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
This Apple-like Innovator is Revolutionizing Healthcare (Ad) AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing.
Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry |
04/10/2024
4:00 PM | Kiniksa Pharmaceuticals (Filer)
| Form PRE 14A | |
04/08/2024
4:20 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
4:21 PM | Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
4:22 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
4:17 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
4:18 PM | Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
4:19 PM | Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
11:21 AM | BlackRock Inc. (Filed by)
Kiniksa Pharmaceuticals (Subject)
| Form SC 13G/A | |
04/03/2024
4:22 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:23 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:25 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
6:32 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
4:00 PM | Kiniksa Pharmaceuticals (Filer)
| Form DEFA14A | |
03/29/2024
6:30 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
6:30 AM | Kiniksa Pharmaceuticals (Filer)
| Form DEFA14A | |
03/11/2024
6:05 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:37 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:24 PM | Kiniksa Pharmaceuticals (Subject)
Patel Sanj K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
5:26 PM | Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:29 PM | Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
4:31 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2024
6:35 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
2:46 PM | Fairmount Funds Management LLC (Filed by)
Kiniksa Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/12/2024
5:06 AM | Kiniksa Pharmaceuticals (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G | |
01/04/2024
6:37 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/21/2023
3:26 PM | Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
3:20 PM | Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
3:46 PM | Kiniksa Pharmaceuticals (Subject)
Paolini John F. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2023
3:33 PM | Kiniksa Pharmaceuticals (Issuer)
Levy Richard S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
3:15 PM | Kiniksa Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2023
6:35 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
3:26 PM | Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
6:03 PM | Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
6:04 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
This Apple-like Innovator is Revolutionizing Healthcare (Ad) AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing.
Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry |
09/06/2023
6:06 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
6:06 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
6:07 PM | Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
6:08 PM | Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
4:26 PM | Kiniksa Pharmaceuticals (Subject)
Paolini John F. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/18/2023
3:32 PM | HHLR ADVISORS, LTD. (Filed by)
Kiniksa Pharmaceuticals (Subject)
| Form SC 13G/A | |
07/25/2023
6:40 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2023
3:15 PM | Kiniksa Pharmaceuticals (Issuer)
Quart Barry D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:15 PM | Cole G Bradley (Reporting)
Kiniksa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:15 PM | Kiniksa Pharmaceuticals (Issuer)
Popovits Kimberly J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:15 PM | Kiniksa Pharmaceuticals (Issuer)
Levy Richard S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:15 PM | Kiniksa Pharmaceuticals (Issuer)
McCain Tracey L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:15 PM | Kiniksa Pharmaceuticals (Issuer)
Malley Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
4:37 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Kiniksa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
4:09 PM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
